High levels of eIF4E are able to confer resistance to apoptosis in cells exposed to a variety of death stimuli [6], [7], and eIF4E activity is regulated by the anti-apoptotic protein kinase Akt, an enzyme implicated in tumour cell survival and resistance to therapy [8]. The gene discussed is AKT1; the disease is neoplasm.